Forecast & Rating8 analysts currently cover Day One Biopharmaceuticals, with about 0.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $21.50, about 0.1% downside from the current price of $21.53. For you, this means most institutions are cautious on Day One Biopharmaceuticals's outlook. Data as of Apr 8, 2026; for reference only and not investment advice.
Apr 6, 2026Price forecast
$21.50-0.14%
Forecast & RatingHold
8analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateApr 20, 2026
Forecast met2.6%
Stock price$21.53
Avg. target$21.5
High target$22
Low target$22
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.